Source: Clinical Lab Products

OmniSeq: Labcorp, OmniSeq Launch Insight Next-Gen Sequencing Platform for Precision Oncology

OmniSeq Insight is a pan-cancer, solid tumor test that combines two different treatment paradigms: genomic and immune profiling.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Margot Schoenborn's photo - CEO of OmniSeq

CEO

Margot Schoenborn

CEO Approval Rating

90/100

Read more